Novoridge, a leading Chemistry CRO in radiopharmaceutical and theranostics precursors development services, supports accelerating your radiopharmaceuticals and theranostics drug development efforts. Contact us to know more about how Novoridge can support your project and help you achieve your goals efficiently and cost-effectively.
Theranostics combines the concepts of therapeutics and diagnostics. Radiotracer compound composed of radiation and chemical that selectively bind to specific targets in the body. It describes the combination of using one radioactive drug to identify (diagnose) a tumor and the second radioactive drug for delivery therapy to treat tumors.
Our team of experienced medicinal and radiochemistry experts is here to support the development of your project, whether it involves small molecules or peptides as diagnostic or therapeutic radiopharmaceuticals.
We offer comprehensive support from core design to focused library synthesis and lead optimization. For the most promising compounds, we also synthesize primary precursor compounds, utilizing optimized leaving/protecting group combinations to ensure high-yield radiolabeling reactions.Contact us to know more about how Novoridge can support your project and help you achieve your goals efficiently and cost-effectively.
| Target Identification | Hit to Lead approaches | Lead Discovery | Lead Optimization | Preclinical Studies |
|---|---|---|---|---|
|
|
|
|
Pharmacology PK properties Safe for clinical dosing and micro dosing GLP |